1 link tagged with all of: biotech + virtual drug trials + clinical trials + ai
Click any tag below to further narrow down your results
Links
Copenhagen startup BioinvestGPT runs virtual versions of drug trials with its AI models, and it says its forecasts were right in five of six cases so far. The companies behind these tools hope that testing drugs in simulation first will help more of them succeed in real human studies.
- BioinvestGPT shared its predictions for several high-profile drug trials with Reuters in July, before those results were public.
- The firm has been correct in five of six of those forecasts so far, a small sample that still needs more track record to judge.
- The pitch is that better virtual trials could cut the failure rate of expensive human studies.